[{"address1": "21925 W. Field Parkway", "address2": "Suite 235", "city": "Deer Park", "state": "IL", "zip": "60010-7208", "country": "United States", "phone": "847 787 7361", "website": "https://www.etonpharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and dehydrated alcohol injection to treat methanol poisoning. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis; Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis; EPRONTIA, a liquid formulation of topiramate; ZONISADE, a liquid formulation of zonisamide for the treatment of partial seizures in patients with epilepsy; and Lamotrigine for Oral Suspension for the treatment of epilepsy. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.", "fullTimeEmployees": 28, "companyOfficers": [{"maxAge": 1, "name": "Mr. Sean E. Brynjelsen", "age": 51, "title": "President, CEO & Director", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": 868126, "exercisedValue": 0, "unexercisedValue": 290000}, {"maxAge": 1, "name": "Mr. James R. Gruber CPA", "age": 51, "title": "CFO, Treasurer & Secretary", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": 457584, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David C. Krempa", "age": 34, "title": "Chief Business Officer", "yearBorn": 1989, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ingrid  Hoos", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin  Guthrie", "title": "Executive VP of Commercial Operations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.45, "open": 4.45, "dayLow": 4.3097, "dayHigh": 4.52, "regularMarketPreviousClose": 4.45, "regularMarketOpen": 4.45, "regularMarketDayLow": 4.3097, "regularMarketDayHigh": 4.52, "beta": 1.203, "trailingPE": 49.333332, "forwardPE": 17.076923, "volume": 58147, "regularMarketVolume": 58147, "averageVolume": 87175, "averageVolume10days": 80040, "averageDailyVolume10Day": 80040, "bidSize": 1100, "askSize": 1800, "marketCap": 113923296, "fiftyTwoWeekLow": 2.42, "fiftyTwoWeekHigh": 5.81, "priceToSalesTrailing12Months": 3.4704144, "fiftyDayAverage": 4.1334, "twoHundredDayAverage": 3.9062, "currency": "USD", "enterpriseValue": 97684280, "profitMargins": 0.06799, "floatShares": 19970443, "sharesOutstanding": 25658400, "sharesShort": 381209, "sharesShortPriorMonth": 363834, "sharesShortPreviousMonthDate": 1702598400, "dateShortInterest": 1705017600, "sharesPercentSharesOut": 0.0149, "heldPercentInsiders": 0.12984, "heldPercentInstitutions": 0.27063, "shortRatio": 3.7, "shortPercentOfFloat": 0.015700001, "impliedSharesOutstanding": 25658400, "bookValue": 0.658, "priceToBook": 6.7477207, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": 2232000, "trailingEps": 0.09, "forwardEps": 0.26, "enterpriseToRevenue": 2.976, "enterpriseToEbitda": 36.572, "52WeekChange": 0.23955429, "SandP52WeekChange": 0.20233083, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "ETON", "underlyingSymbol": "ETON", "shortName": "Eton Pharmaceuticals, Inc.", "longName": "Eton Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1542119400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "fbcd977f-686a-3d1e-ae47-b3ae800e35f4", "messageBoardId": "finmb_435353222", "gmtOffSetMilliseconds": -18000000, "currentPrice": 4.44, "targetHighPrice": 10.0, "targetLowPrice": 10.0, "targetMeanPrice": 10.0, "targetMedianPrice": 10.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 22070000, "totalCashPerShare": 0.86, "ebitda": 2671000, "totalDebt": 5831000, "quickRatio": 2.46, "currentRatio": 2.613, "totalRevenue": 32827000, "debtToEquity": 34.519, "revenuePerShare": 1.285, "returnOnAssets": 0.043899998, "returnOnEquity": 0.15901, "freeCashflow": 7602250, "operatingCashflow": 9268000, "revenueGrowth": 1.183, "grossMargins": 0.72473997, "ebitdaMargins": 0.08137, "operatingMargins": -0.07797, "financialCurrency": "USD", "trailingPegRatio": null}]